openPR Logo
Press release

The Hemarthrosis Treatment Market to witness an exponential spike in the next decade

12-21-2020 02:56 PM CET | Health & Medicine

Press release from: Persistence Market Research

Hemophilia is a genetic disorder which is caused when factor IX or VIII also known as the clotting protein is either missing or defective. Hemophilia involves a common complication of joint bleeding. Excess bleeding of the joints result into a permanent damage to the patient’s joint, which sometimes could also lead to permanent disability. The frequency and severity of the joint bleeding determines how likely a patient is to develop permanent disability. This condition caused by joint bleeding leading to the swelling of the joints, deformity, and severe pain is referred to as hemarthrosis, as the symptoms are quite similar to arthritis symptoms but also, involves blood. The bleeding in the joint immensely affects the surrounding cartilage of the bone. Hemarthrosis treatment entirely depends on the underlying cause of the joint bleeding and also, on the severity of the damage of the joint. Different surgeries and therapies are available for hemarthrosis treatment and several researches are ongoing, globally. Hemophilia take factor replacement therapy is one hemarthrosis treatment option that is widely used for hemarthrosis treatment. This replacement therapy involves a medication for the replacement of the missing or defective clotting protein, which prevents hemarthrosis from happening in the first place.
Increasing incidence of hemarthrosis because of high incidence of hemophilia across regions is expected high demand for hemarthrosis treatment throughout the forecast period. Several factors, such as, increasing number of trauma cases by any injury or sprain, increased use of anticoagulants, high incidence of inflammation of the joints, and increasing incidence of arthritis and leukemia are also some of the primary factors that might contribute to the market growth of hemarthrosis treatment market during the forecast period. Increase in government funding and support for ongoing research and development related to hemarthrosis treatment might also boost market growth for hemarthrosis treatment across regions during the forecast period. However, high costs associated with replacement therapies and surgeries for hemarthrosis treatment and less affordability for hemarthrosis treatment in the developing regions could obstruct market growth for hemarthrosis treatment market during the forecast period.

To remain ‘ahead’ of your competitors, request for a sample here@
https://www.persistencemarketresearch.com/samples/28768

On the basis of Treatment Type, Hemarthrosis Treatment Market can be segmented as:
• Surgical hemarthrosis treatment
o Synovectomy
 Radioactive
 Arthroscopic
 Open
o Joint Replacement
 Cheilectomy
 Arthrodesis
 Osteotomy
o Drugs
 Antifibrinolytics
 GNRH Agonist
 Plasma expanders
 Others
On the basis of End Use, Hemarthrosis Treatment Market can be segmented as:
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research Centers
• Others
According to various hemarthrosis treatment reports_bk_01_01_2020 published on the National Institute of Biotechnology, approximately 50% patients dealing with hemophilia develop hemarthrosis requiring hemarthrosis treatment. Trauma cases having joint injuries increases the chance of developing hemarthrosis in this population. A suspected hemarthrosis can be assessed by CT (computed tomography) scan, plain radiographs, or magnetic resonance imaging (MRI). Initial hemarthrosis treatment of any acute hemarthrosis includes ice, immobilization, and compression. Analgesia is required in the acute period for pain management for hemarthrosis treatment. Traumatic hemarthrosis usually happens in the situation of intra-articular injury with osseous, ligamentous, and/or cartilage damage contributing to a synovial blood fluid collection. Lipohemarthrosis stems development from marrow fat leakage into the synovial fluid is caused because of extensive intra-articular soft tissue injury or the intra-capsular fractures.

To receive extensive list of important regions, Request Methodology here @
https://www.persistencemarketresearch.com/methodology/28768

Growth of the hemarthrosis treatment market is highly attributed to the high incidence of hemophilia cases and trauma injuries cases in the North America region. Consistently increasing awareness on the wide hemarthrosis treatment option available and increase in healthcare expenditure is also expected to drive market growth for hemarthrosis treatment in the region throughout the forecast period. Europe’s market for hemarthrosis treatment is expected to witness a robust market growth owing it to the improved healthcare infrastructure in the region and increase in government support for research and development of hemarthrosis treatment. Middle East & Africa’s hemarthrosis treatment market and Latin America’s market for hemarthrosis treatment is expected to grow at a decent rate owing it to less awareness on hemophilia and hemarthrosis treatment.
Some of the market participants in the Global Hemarthrosis Treatment market identified across the value chain include: Novartis AG, Pfizer Inc., Sun Pharmaceuticals Ltd, Merck KGaA, Bayer Healthcare, BioMarin Pharmaceutical, Inc., Biogen, Chugai Pharmaceutical Co., Novo Nordisk, and Shire Plc.

You Can Request for TOC Here @ https://www.persistencemarketresearch.com/toc/28768

Naved Beg
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PMR.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Hemarthrosis Treatment Market to witness an exponential spike in the next decade here

News-ID: 2214317 • Views:

More Releases from Persistence Market Research

Alcohol Breathalyzer and Drug Testing Equipment Market Sales Estimated to Hit USD 13,393.3 Million by 2026| Says Persistence Market Research
Alcohol Breathalyzer and Drug Testing Equipment Market Sales Estimated to Hit US …
Introduction: The alcohol breathalyzer and drug testing equipment market plays a critical role in ensuring public safety, workplace compliance, and law enforcement efficiency. These devices are extensively used by traffic authorities, employers, healthcare providers, and educational institutions to detect alcohol and substance abuse. They improve accuracy, speed, and reliability in screening processes, making them indispensable in modern safety and regulatory frameworks. Download to explore critical insights from our Report in this
Europe Organic Fertilizer Market Valued at US$ 3.53 Bn by 2032 Driven by Sustainable Farming Practices
Europe Organic Fertilizer Market Valued at US$ 3.53 Bn by 2032 Driven by Sustain …
Introduction: The Shift Toward Sustainable Agriculture in Europe Europe is witnessing a significant transformation in its agricultural practices, with sustainability emerging as the primary focus. As concerns over soil health, food safety, and environmental degradation rise, farmers and policymakers are increasingly shifting from chemical-based farming to organic cultivation methods. This shift has created a strong demand for organic fertilizers, which are not only environmentally friendly but also enhance soil fertility, crop
Solar Charge Controller Market Growth to Reach US$ 5,474.2 Mn by 2032, Driven by Rising Renewable Energy Adoption
Solar Charge Controller Market Growth to Reach US$ 5,474.2 Mn by 2032, Driven by …
Introduction: The Backbone of Solar Power Systems As the world accelerates its transition toward renewable energy, solar power has emerged as one of the most accessible and sustainable solutions for both residential and commercial applications. At the heart of every efficient solar energy system lies the solar charge controller-a critical component that regulates the flow of electricity between solar panels, batteries, and connected devices. By preventing overcharging and extending battery life,
Biodiesel Fuel Market Growth to Reach US$ 75.8 Bn by 2032, Driven by Sustainable Energy Demand
Biodiesel Fuel Market Growth to Reach US$ 75.8 Bn by 2032, Driven by Sustainable …
Introduction: The Role of Biodiesel in a Sustainable Future As the global energy landscape continues to undergo a transition toward cleaner and greener sources, biodiesel has emerged as one of the most promising alternatives to fossil fuels. Derived from renewable resources such as vegetable oils, animal fats, and recycled cooking oil, biodiesel offers a sustainable pathway to reduce carbon emissions while supporting energy security. Its compatibility with existing diesel engines, cost-efficiency

All 5 Releases


More Releases for Hemarthrosis

In-depth Analysis of Sterile Cover Market Size, Share, and Growth Trends 2024-20 …
According to WGR's most recent report, the Sterile Cover Market 2024-2032 is anticipated to grow rapidly over the coming years. Through the process of research, consolidation, market size, overview, and review of data obtained from multiple sources, the Sterile Cover Market report provides a meaningful representation of the region. In the Sterile Cover Market Study, you will find details about market dynamics, drivers, restraints, challenges, threats, potential growth opportunities, market trends,
Ginseng Drink Market Overall Study Report 2024-2032 | VPX Sports, Reign Total Bo …
The Ginseng Drink Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. It's like a compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its future. This report becomes a strategic ally for companies, stakeholders, and industry players, offering a
Communications Interface Market Size, Share and Forecast By Key Players-Omron, H …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Communications Interface market is anticipated to grow at a compound annual growth rate (CAGR) of 9.48% between 2024 and 2031. The market is expected to grow to USD 14.09 Billion by 2024. The valuation is expected to reach USD 26.55 Billion by 2031. The increasing usage of modern communication technologies across numerous industries is driving the rapid expansion of the communications interface
Closed System Transfer Devices Cstd Market Trends, Size, Segments, Key Growth Dr …
In 2024, the WiseGuy Reports latest published research report on "Closed System Transfer Devices Cstd market growth is growing steadily with exponential rate and a rising adoption of strategies by top industry players, over the projected horizon 2024 to 2032". The high adoption of advanced technology and the presence of large players in this region are likely to create ample growth opportunities for the Closed System Transfer Devices Cstd market.
Coagulation Factor Deficiency Market Outlook Report 2032 | Pfizer, Grifols, Biog …
DelveInsight's "Coagulation Factor Deficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Coagulation Factor Deficiency, historical and forecasted epidemiology as well as the Coagulation Factor Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Coagulation Factor Deficiency market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted
Brazil Hemophilia A Therapeutics Market Growing Trade Among Emerging Economies O …
Report Overview The Brazil Hemophilia A Therapeutics market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period. Brazil is the country with the third largest population of people with hemophilia. Hemophilia A is a bleeding disorder resulting from the inherited deficiency of coagulation factor VIII (FVIII), which is transmitted recessively and linked to the